Hydroquinazoline Derivatives as Novel Natriuretic Peptide Receptor 1 (NPR1) Activators
- PMID: 40104790
- PMCID: PMC11912258
- DOI: 10.1021/acsmedchemlett.5c00013
Hydroquinazoline Derivatives as Novel Natriuretic Peptide Receptor 1 (NPR1) Activators
Abstract
This patent highlights hydroquinazoline compounds and their pharmaceutically acceptable salts, as well as compositions and methods of preparation. The compounds in this invention were evaluated for their potency on Natriuretic Peptide Receptor 1 (NPR1), a receptor guanylate cyclase known to play a critical role in lowering blood pressure and blood volume.
Published 2025 by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous